COO Cheryl Gault resigns; effective at close of asset sale to JW Celtics

Cyclerion Therapeutics, Inc.

Cheryl Gault resigned as COO effective on closing of the proposed sale of certain assets to JW Celtics Investment Corp.
Separation agreement provides six months of base salary and COBRA subsidies; stock option exercise period extended to 24 months.
Chairman Errol De Souza thanked Gault for her service to operations and the sale transaction.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Cheryl Gault

Chief Operating Officer

CYCN · Cyclerion Therapeutics, Inc.

Filed: June 27, 2023, 7:59 PM ET

On June 26, 2023, Cheryl Gault announced her resignation as the Chief Operating Officer of Cyclerion Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Cheryl Gault resigned as Chief Operating Officer at Cyclerion Therapeutics, Inc..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On June 26, 2023, Cheryl Gault announced her resignation as the Chief Operating Officer of Cyclerion Therapeutics, Inc.

View on SEC.gov

Cyclerion Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-030168

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.